27 1 General Introduction 63. Mizushima, N. et al. A protein conjugation system essential for autophagy. Nature 395–398 (1998). 64. Aman, Y. et al. Autophagy in healthy aging and disease. Nature Aging vol. 1 634–650 Preprint at https://doi.org/10.1038/s43587-021-00098-4 (2021). 65. Klionsky, D. J. et al. Autophagy in major human diseases. EMBO J 40, (2021). 66. Liu, W. J. et al. p62 links the autophagy pathway and the ubiqutin-proteasome system upon ubiquitinated protein degradation. Cellular and Molecular Biology Letters vol. 21 Preprint at https://doi.org/10.1186/s11658-016-0031-z (2016). 67. Chen, R. et al. The general amino acid control pathway regulates mTOR and autophagy during serum/glutamine starvation. Journal of Cell Biology 206, 173–182 (2014). 68. Tan, H. W. S., Sim, A. Y. L. & Long, Y. C. Glutamine metabolism regulates autophagydependent mTORC1 reactivation during amino acid starvation. Nat Commun 8, (2017). 69. Ghislat, G. & Knecht, E. Regulation of Autophagy by Amino Acid Starvation Involving Ca2+. in Autophagy: Cancer, Other Pathologies, Inflammation, Immunity, Infection, and Aging vol. 6 69–79 (Elsevier Inc., 2015). 70. Singh, R. & Cuervo, A. M. Autophagy in the cellular energetic balance. Cell Metabolism vol. 13 495–504 Preprint at https://doi.org/10.1016/j.cmet.2011.04.004 (2011). 71. Liu, C. et al. Functional amino acids and autophagy: Diverse signal transduction and application. International Journal of Molecular Sciences vol. 22 Preprint at https://doi. org/10.3390/ijms222111427 (2021). 72. Sakai, Y., Oku, M., van der Klei, I. J. & Kiel, J. A. K. W. Pexophagy: Autophagic degradation of peroxisomes. Biochimica et Biophysica Acta - Molecular Cell Research vol. 1763 1767– 1775 Preprint at https://doi.org/10.1016/j.bbamcr.2006.08.023 (2006). 73. Yoshii, S. R. & Mizushima, N. Monitoring and measuring autophagy. International Journal of Molecular Sciences vol. 18 Preprint at https://doi.org/10.3390/ijms18091865 (2017). 74. Van Raalte, D. H., Li, M., Haydn Pritchard, P. & Wasan, K. M. Peroxisome ProliferatorActivated Receptor (PPAR): A Pharmacological Target with a Promising Future. Pharm Res 21, 1531–1538 (2004). 75. Motojima, K., Passilly, P., Peters, J. M., Gonzalez, F. J. & Latruffe, N. Expression of Putative Fatty Acid Transporter Genes Are Regulated by Peroxisome Proliferatoractivated Receptor and Activators in a Tissue-and Inducer-specific Manner*. J Biol Chem 273, 16710–16714 (1998). 76. Berger, J. & Moller, D. E. The Mechanisms of action of PPARS. Annu Rev Med 53, 409–435 (2002). 77. Lalwani, N. D. et al. Evaluation of Selected Hypolipidemic Agents for the Induction of Peroxisomal Enzymes and Peroxisome Proliferation in the Rat Liver. Human Toxicol 2, 27–48 (1983). 78. Katsiki, N. et al. The Role of Fibrate Treatment in Dyslipidemia: An Overview. Curr Pharm Des 19, 3124–3131 (2013). 79. Kersten, S. et al. Peroxisome proliferator–activated receptor amediates the adaptive response to fasting. J Clin Invest (1999) doi:10.1172/JCI6223.
RkJQdWJsaXNoZXIy MTk4NDMw